A
Alan V. Nguyen
Researcher at University of California, Davis
Publications - 8
Citations - 331
Alan V. Nguyen is an academic researcher from University of California, Davis. The author has contributed to research in topics: Timolol & Wound healing. The author has an hindex of 3, co-authored 6 publications receiving 113 citations. Previous affiliations of Alan V. Nguyen include Shriners Hospitals for Children.
Papers
More filters
Journal ArticleDOI
The Dynamics of the Skin's Immune System
TL;DR: The defensive components of the skin are discussed and the function of skin-resident immune cells in homeostasis and their role in wound healing are focused on.
Journal ArticleDOI
Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice.
Hsin-ya Yang,Fernando A. Fierro,Michelle So,Daniel J. Yoon,Alan V. Nguyen,Alan V. Nguyen,Anthony Gallegos,Michelle D. Bagood,Tomas Rojo-Castro,Alan Alex,Heather Stewart,Marianne Chigbrow,Mohan R. Dasu,Thomas R. Peavy,Athena M. Soulika,Athena M. Soulika,Jan A. Nolta,Roslyn Rivkah Isseroff +17 more
TL;DR: Overall, the combination device successfully improved wound healing and reduced the wound inflammatory response in the diabetic mouse model, suggesting that it could be translated to a therapy for patients with diabetic chronic wounds.
Journal ArticleDOI
Topical fluoxetine as a novel therapeutic that improves wound healing in diabetic mice
Chuong Nguyen,Danielle M. Tartar,Michelle D. Bagood,Michelle So,Alan V. Nguyen,Anthony Gallegos,Daniel R. Fregoso,J. A. Serrano,Duc Nguyen,Doniz Degovics,Andrew P Adams,Benjamin Harouni,J. Fuentes,Mélanie G. Gareau,Robert W. Crawford,Athena M. Soulika,Athena M. Soulika,Roslyn Rivkah Isseroff +17 more
TL;DR: It is demonstrated that topically applied FLX improves cutaneous wound healing in vivo and that FLX not only increases keratinocyte migration but also shifts the local immune milieu toward a less inflammatory phenotype in vivo without altering behavior.
Journal ArticleDOI
PD-1 Blockade Reverses Obesity-Mediated T Cell Priming Impairment.
Catherine T. Le,Lam T. Khuat,Sofia E. Caryotakis,Marilyn Wang,Marilyn Wang,Cordelia Dunai,Alan V. Nguyen,Alan V. Nguyen,Logan V Vick,Kevin Stoffel,Bruce R. Blazar,Arta M. Monjazeb,William J. Murphy,Athena M. Soulika,Athena M. Soulika +14 more
TL;DR: It is demonstrated that obesity impairs antigen-specific T cell priming, but this can be reversed with PD-1 blockade, and the results suggest that PD- 1 blockade may increase the risk of autoimmune toxicities, particularly in obesity.
Book ChapterDOI
Myeloid Cells in Multiple Sclerosis
TL;DR: Significant advances made in recent years delineating myeloid cell functions within the CNS both in homeostasis and MS are reviewed.